Zheng Zhang , Huijie Xu , Yun Meng , Yangxinyu Yan , Yuanyuan Wang
{"title":"Association between depressive symptoms and all-cause and cardiovascular mortality in diabetes patients: A national cohort study","authors":"Zheng Zhang , Huijie Xu , Yun Meng , Yangxinyu Yan , Yuanyuan Wang","doi":"10.1016/j.jad.2025.119957","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Depression is a significant psychological burden frequently observed among diabetic patients, and it has been increasingly linked to higher mortality risks, particularly from cardiovascular diseases. Clarifying why depression contributes to these risks is essential for effective intervention strategies.</div></div><div><h3>Methods</h3><div>This national cohort study utilized data from the National Health and Nutrition Examination Survey (NHANES) (2005–2018), analyzing 4743 diabetic patients. Depressive symptoms were assessed using the PHQ-9 scale, and mortality data were linked through the National Death Index. The Systemic Immune-Inflammation Index (SII) was calculated to evaluate its mediating role in the relationship between depressive symptoms and mortality.</div></div><div><h3>Results</h3><div>Depressive symptoms significantly increased all-cause (HR = 1.32, 95 % CI = 1.07–1.63) and cardiovascular mortality (HR = 1.73, 95 % CI = 1.23–2.42) even after adjustments. SII mediated 8.0 % of the association with all-cause mortality and 6.0 % with cardiovascular mortality. Subgroup analyses revealed varied impacts based on demographic characteristics.</div></div><div><h3>Conclusion</h3><div>Depressive symptoms are linked to heightened mortality risks in diabetic patients, with SII serving as a critical mediating factor. Comprehensive management addressing both mental health and inflammation is essential for improving outcomes in this population.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"391 ","pages":"Article 119957"},"PeriodicalIF":4.9000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of affective disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165032725013990","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Depression is a significant psychological burden frequently observed among diabetic patients, and it has been increasingly linked to higher mortality risks, particularly from cardiovascular diseases. Clarifying why depression contributes to these risks is essential for effective intervention strategies.
Methods
This national cohort study utilized data from the National Health and Nutrition Examination Survey (NHANES) (2005–2018), analyzing 4743 diabetic patients. Depressive symptoms were assessed using the PHQ-9 scale, and mortality data were linked through the National Death Index. The Systemic Immune-Inflammation Index (SII) was calculated to evaluate its mediating role in the relationship between depressive symptoms and mortality.
Results
Depressive symptoms significantly increased all-cause (HR = 1.32, 95 % CI = 1.07–1.63) and cardiovascular mortality (HR = 1.73, 95 % CI = 1.23–2.42) even after adjustments. SII mediated 8.0 % of the association with all-cause mortality and 6.0 % with cardiovascular mortality. Subgroup analyses revealed varied impacts based on demographic characteristics.
Conclusion
Depressive symptoms are linked to heightened mortality risks in diabetic patients, with SII serving as a critical mediating factor. Comprehensive management addressing both mental health and inflammation is essential for improving outcomes in this population.
期刊介绍:
The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, mood spectrum, emotions and personality, anxiety and stress. It is interdisciplinary and aims to bring together different approaches for a diverse readership. Top quality papers will be accepted dealing with any aspect of affective disorders, including neuroimaging, cognitive neurosciences, genetics, molecular biology, experimental and clinical neurosciences, pharmacology, neuroimmunoendocrinology, intervention and treatment trials.